dermatan sulfate has been researched along with Acute Disease in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 8 (38.10) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, HP; Coffey, CS; Davis, PH; Froehler, MT; Jorge, RE; Leira, EC; Morton, SM | 1 |
| Anand, V; Martí-Carvajal, AJ; Solà, I | 1 |
| Hagiwara, S; Iwasaka, H; Matsumoto, S; Mizunaga, S; Nishida, T; Noguchi, T; Saikawa, T; Shingu, C; Uchida, T | 1 |
| Kubo, Y; Miseki, T; Oku, T; Sakai, T; Sugata, H; Yamakawa, A | 1 |
| Cardona, AF; Martí-Carvajal, AJ; Simancas, D | 1 |
| Agnelli, G; Imberti, D; Silvestrini, E; Taliani, MR; Verso, M | 1 |
| Adams, HP; Clarke, WR; Ringman, JM; Saver, JL; Woolson, RF | 1 |
| Bruno, A; Saha, C; Williams, LS | 1 |
| Makhoul, RG; Sobel, M; Sternbergh, WC | 1 |
| Boschetti, C; Cofrancesco, E; Cortellaro, M; Gianese, F; Leonardi, P | 1 |
| Magnani, HN; Ruys, AH | 1 |
| Banga, JD; Brouwer, CB; de Valk, HW; Hart, HC; Meuwissen, OJ; Nieuwenhuis, HK; Sixma, JJ; van der Graaf, Y; Wester, JP | 1 |
| Förster, G; Fraiture, B; Hansen, C; Kahaly, G; Otto, E; Rouhi, R | 1 |
| Aiello, VD; Gutierrez, PS; Higuchi, ML; Lopes, EA; Reis, MM; Stolf, NA | 1 |
| Ariano, RE; Wazny, LD | 1 |
| Armstrong, SB; Chilukuri, V; Edwards, LJ; Goldstein, LB; Hoff, J; Horner, RD; Jones, MR; Matchar, DB | 1 |
| Hanley, DF; Keyl, PM; McBee, NA; Razumovsky, AY; Ulatowski, JA; Varelas, PN; Wijman, CA; Williams, MA; Wityk, RJ | 1 |
| Counsell, C; Sandercock, P | 1 |
| Boschetti, C; Cofrancesco, E; Cortellaro, M; Leonardi, P | 1 |
| Côte, R; Geerts, W; Gent, M; Ginsberg, JS; Jay, R; Leclerc, J; Levine, MN; Neemeh, J; Powers, PJ; Turpie, AG | 1 |
| Andrew, M; Carter, CJ; Gent, M; Hirsh, J; Hull, RD; Jay, RM; Levine, MN; Magnani, HN; Powers, PJ; Turpie, AG | 1 |
4 review(s) available for dermatan sulfate and Acute Disease
| Article | Year |
|---|---|
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.
Topics: Acute Disease; Anticoagulants; Chronic Disease; Dermatan Sulfate; Disseminated Intravascular Coagulation; Humans; Leukemia; Protein C; Randomized Controlled Trials as Topic; Thrombomodulin; Tranexamic Acid | 2015 |
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.
Topics: Acute Disease; Anticoagulants; Chronic Disease; Dermatan Sulfate; Disseminated Intravascular Coagulation; Humans; Leukemia; Protein C; Randomized Controlled Trials as Topic; Thrombomodulin; Tranexamic Acid | 2011 |
Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient.
Topics: Acute Disease; Anticoagulants; Antineoplastic Agents; Chondroitin Sulfates; Critical Care; Dermatan Sulfate; Disease Management; Drug Combinations; Fibrinolytic Agents; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Interleukin-11; Recombinant Proteins; Thrombocytopenia; Thrombopoietin | 2000 |
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
Topics: Acute Disease; Anticoagulants; Brain Ischemia; Chondroitin Sulfates; Databases, Factual; Dermatan Sulfate; Drug Combinations; Enoxaparin; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Odds Ratio; Pulmonary Embolism; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome; Venous Thrombosis | 2002 |
7 trial(s) available for dermatan sulfate and Acute Disease
| Article | Year |
|---|---|
Frequency, risk factors, anatomy, and course of unilateral neglect in an acute stroke cohort.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Basal Ganglia; Brain Ischemia; Cerebral Cortex; Cerebral Infarction; Chondroitin Sulfates; Cohort Studies; Dermatan Sulfate; Dominance, Cerebral; Double-Blind Method; Drug Combinations; Female; Heparitin Sulfate; Humans; Incidence; Male; Middle Aged; Perceptual Disorders; Risk Factors; Severity of Illness Index; Thalamus | 2004 |
Dermatan sulphate for the treatment of disseminated intravascular coagulation (DIC) in acute leukemia: a randomised, heparin-controlled pilot study.
Topics: Acute Disease; Adult; Aged; Dermatan Sulfate; Disseminated Intravascular Coagulation; Female; Hematologic Tests; Humans; Leukemia; Male; Middle Aged; Pilot Projects; Prospective Studies; Treatment Outcome | 1994 |
Risk factors for bleeding during treatment of acute venous thromboembolism.
Topics: Acenocoumarol; Acute Disease; Adult; Aged; Body Surface Area; Chondroitin Sulfates; Comorbidity; Dermatan Sulfate; Drug Combinations; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Neoplasms; Odds Ratio; Prospective Studies; Risk Factors; Single-Blind Method; Thromboembolism; Thrombolytic Therapy | 1996 |
Diagnostic impact of early transcranial Doppler ultrasonography on the TOAST classification subtype in acute cerebral ischemia.
Topics: Acute Disease; Aged; Antifibrinolytic Agents; Brain Ischemia; Cerebrovascular Circulation; Chondroitin Sulfates; Dermatan Sulfate; Female; Heparitin Sulfate; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Risk Factors; Tomography, X-Ray Computed; Ultrasonography, Doppler, Transcranial | 2001 |
Dermatan sulphate in acute leukaemia.
Topics: Acute Disease; Aged; Dermatan Sulfate; Disseminated Intravascular Coagulation; Heparin; Humans; Leukemia; Pilot Projects | 1992 |
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antithrombin III; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Fibrinolytic Agents; Follow-Up Studies; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombophlebitis | 1992 |
Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Female; Fibrinolytic Agents; Follow-Up Studies; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Radiography; Random Allocation; Thrombosis; Time Factors | 1987 |
10 other study(ies) available for dermatan sulfate and Acute Disease
| Article | Year |
|---|---|
The NIHSS supplementary motor scale: a valid tool for multidisciplinary recovery trials.
Topics: Acute Disease; Anticoagulants; Brain Damage, Chronic; Brain Ischemia; Chondroitin Sulfates; Clinical Trials as Topic; Confounding Factors, Epidemiologic; Dermatan Sulfate; Female; Glasgow Outcome Scale; Heparitin Sulfate; Humans; Male; Middle Aged; Motor Activity; Movement Disorders; Multicenter Studies as Topic; Prognosis; Recovery of Function; Retrospective Studies; Severity of Illness Index; Stroke; Stroke Rehabilitation; Treatment Outcome | 2013 |
Danaparoid sodium attenuates the effects of heat stress.
Topics: Acute Disease; Animals; Anticoagulants; Antithrombin III; Chondroitin Sulfates; Cytokines; Dermatan Sulfate; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Heat Exhaustion; Heat Stroke; Heparitin Sulfate; HMGB1 Protein; Inflammation; Intestine, Small; Liver; Lung; Male; Nitrates; Nitric Oxide; Nitrites; Peptide Hydrolases; Rats; Rats, Wistar; Survival Rate | 2011 |
[A case of portal vein thrombosis complicating acute cholangitis treated successfully with danaparoid sodium].
Topics: Acute Disease; Aged, 80 and over; Anticoagulants; Cholangitis; Chondroitin Sulfates; Dermatan Sulfate; Female; Gallstones; Heparitin Sulfate; Humans; Portal Vein; Thrombosis | 2010 |
Successful treatment with dermatan sulfate in six patients with heparin-induced thrombocytopenia and acute venous thromboembolism.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Child; Dermatan Sulfate; Female; Heparin; Humans; Male; Middle Aged; Thrombocytopenia; Thromboembolism; Treatment Outcome; Venous Thrombosis | 2003 |
Using change in the National Institutes of Health Stroke Scale to measure treatment effect in acute stroke trials.
Topics: Acute Disease; Anticoagulants; Brain Ischemia; Chondroitin Sulfates; Clinical Trials as Topic; Cohort Studies; Data Interpretation, Statistical; Dermatan Sulfate; Heparitin Sulfate; Humans; National Institutes of Health (U.S.); Odds Ratio; Placebos; Regression Analysis; ROC Curve; Sensitivity and Specificity; Severity of Illness Index; Stroke; Treatment Outcome; United States | 2006 |
Heparinoids with low anticoagulant potency attenuate postischemic endothelial cell dysfunction.
Topics: Acute Disease; Animals; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Dextran Sulfate; Endothelium, Vascular; Heparin; Heparitin Sulfate; Hindlimb; In Vitro Techniques; Ischemia; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vasodilation | 1995 |
Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.
Topics: Acute Disease; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Heparitin Sulfate; Humans; Randomized Controlled Trials as Topic | 1994 |
HPLC glycosaminoglycan analysis in patients with Graves' disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Chondroitin Sulfates; Chromatography, High Pressure Liquid; Dermatan Sulfate; Female; Glycosaminoglycans; Graves Disease; Humans; Hyaluronic Acid; Male; Middle Aged; Prednisolone; Sensitivity and Specificity | 1997 |
Distribution of hyaluronan and dermatan/chondroitin sulfate proteoglycans in human aortic dissection.
Topics: Acute Disease; Adult; Aged; Aorta; Aortic Aneurysm; Biglycan; Chondroitin Sulfate Proteoglycans; Chronic Disease; Dermatan Sulfate; Extracellular Matrix Proteins; Female; Humans; Hyaluronic Acid; Male; Middle Aged; Proteoglycans | 1998 |
Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.
Topics: Acute Disease; Algorithms; Anticoagulants; Chondroitin Sulfates; Data Collection; Dermatan Sulfate; Diagnosis, Computer-Assisted; Drug Combinations; Heparitin Sulfate; Humans; Medical Records Systems, Computerized; Observer Variation; Reproducibility of Results; Retrospective Studies; Stroke | 2001 |